Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: A systematic review and meta-analysis

Jan Philipp Bewersdorf, Smith Giri, Rong Wang, Robert T. Williams, Martin S. Tallman, Amer M. Zeidan, Maximilian Stahl*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations
Original languageEnglish (US)
Issue number5
StatePublished - Jan 2020

ASJC Scopus subject areas

  • Hematology

Cite this